Procainamide Hydrochloride Injection, Solution
Product Images NDC 71872-7113

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Procainamide Hydrochloride (NDC 71872-7113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7113.pdp (7113)

FDA Label Image

71131.pdp (71131)

This is a description of a 10 mL multiple-dose injection of Procainamide HCI, a medication used for certain heart conditions. Each mL of the injection contains 100 mg of Procainamide HCI, with methylparaben added as a preservative and sodium metabisulfite added. The injection may also contain hydrochloric acid (HCI) and/or sodium hydroxide (NaOH) for pH adjustment. It is important not to use the injection if it appears darker than slightly yellow or is discolored in any other way. The injection is manufactured by Hospira, Inc. A lot number and expiration date are also provided.*

FDA Label Image

Structural Formula Procainamide Hydrochloride (Procainamide 01)

FDA Label Image

Logo (Procainamide 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.